bicalutamide has been researched along with acid phosphatase in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Migliari, R; Muscas, G; Usai, E | 1 |
| Lunglmayr, G | 1 |
| Chodak, GW; Kennealey, GT; Schellhammer, PF; Smith, JA; Soloway, MS; Vogelzang, NJ | 1 |
| Chodak, GW; Kennealey, GT; Schellhammer, PF; Smith, JA; Soloway, MS | 1 |
| Channer, K; Cockshott, ID; Denis, L; Newling, D; Soloway, M; Tyrrell, CJ | 1 |
| Heer, R; Leung, HY; Robson, CN; Shenton, BK | 1 |
3 trial(s) available for bicalutamide and acid phosphatase
| Article | Year |
|---|---|
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapy.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Tosyl Compounds | 1995 |
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Humans; Male; Middle Aged; Nitriles; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 1996 |
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.
Topics: Acid Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Humans; Liver Function Tests; Luteinizing Hormone; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 1998 |
3 other study(ies) available for bicalutamide and acid phosphatase
| Article | Year |
|---|---|
Effect of Casodex on sleep-related erections in patients with advanced prostate cancer.
Topics: Acid Phosphatase; Androgen Antagonists; Anilides; Antigens, Neoplasm; Estradiol; Humans; Male; Middle Aged; Nitriles; Penile Erection; Prostate-Specific Antigen; Prostatic Neoplasms; Sleep; Testosterone; Tosyl Compounds | 1992 |
Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Anilides; Estradiol; Follicle Stimulating Hormone; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 1989 |
The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Topics: AC133 Antigen; Acid Phosphatase; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antigens, CD; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblast Growth Factor 7; Glycoproteins; Humans; Integrin alpha2beta1; Keratin-18; Leupeptins; Male; Metribolone; Middle Aged; Neoplastic Stem Cells; Nitriles; Peptides; Phenotype; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Tyrosine Phosphatases; Receptors, Androgen; RNA, Messenger; Signal Transduction; Testosterone Congeners; Tosyl Compounds | 2007 |